Belgium to India: Salicylic Import Trade Route

The Belgium to India Salicylic corridor is one of India's established pharmaceutical import routes from Belgium, with 1 shipments documented worth a combined $3.8K USD. The route is dominated by HYLORIS DEVELOPMENTS SA , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Belgium's salicylic export sector.

Across 1 active Belgium suppliers, the average shipment value stands at $3.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 22.9%, placing it at rank #1 among India's top salicylic import origins globally.

On the Indian buyer side, key Indian importers include MAIVA PHARMA PRIVATE LIMITED . MAIVA PHARMA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $3.8K USD.

India's salicylic imports from Belgium are driven primarily by a handful of large-scale Belgium manufacturers. HYLORIS DEVELOPMENTS SA with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Belgium supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HYLORIS DEVELOPMENTS SA — together account for 100% of total trade value on this route. The average shipment value of $3.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, MAIVA PHARMA PRIVATE LIMITED is the largest importer with 1 shipments worth $3.8K USD — representing 100% of all salicylic imports from Belgium on this route.